: :inin Kyiv (EET)

Section: Asia

      Tajikistan and Ukraine discuss bilateral ties
      Feb08

      Tajikistan and Ukraine discuss bilateral ties

      …read more Source:: AKIpress News Agency

      Kazakhstani-Ukrainian duo wins ATP Challenger men’s doubles title
      Feb07

      Kazakhstani-Ukrainian duo wins ATP Challenger men’s doubles title

      ANTALYA. KAZINFORM – Kazakhstani Alexander Nedovyesov and Denys Molchanov of Ukraine have won the men’s doubles title of the ATP Challenger in Antalya, Turkey, Kazinform has learnt from the Kazakhstan Tennis Federation. …read more Source::...

      Kazakhstani Nedovyesov storms into final at Challenger Antalya 2 Doubles
      Feb05

      Kazakhstani Nedovyesov storms into final at Challenger Antalya 2 Doubles

      NUR-SULTAN. KAZINFORM Kazakhstani tennis player Alexander Nedovyesov and Denys Molchanov of Ukraine have advanced to the final at the Challenger Antalya 2 Doubles with the prize of USD 44,000, the Kazakh Tennis Federation’s press service informs. …read more Source::...

      Free Navalny, EU diplomat tells Russia at rare talks in Moscow
      Feb05

      Free Navalny, EU diplomat tells Russia at rare talks in Moscow

      Sergey Lavrov (left) and Josep Borrell talk during their meeting in Moscow today. (AP pic)MOSCOW: The European Union’s top diplomat appealed to Russia on Friday to free jailed Kremlin critic Alexei Navalny, a case he said had brought EU-Russian ties to a low, drawing a robust response from Moscow which called the EU an unreliable partner....

      Kazakhstani Nedovyesov and doubles partner propel into ATP challenger semis
      Feb05

      Kazakhstani Nedovyesov and doubles partner propel into ATP challenger semis

      ANTALYA. KAZINFORM – Kazakhstani Alexander Nedovyesov and Denys Molchanov of Ukraine have advanced to the semifinals of the ATP Challenger in Antalya, Turkey with the prize fund of €44,820, Kazinform has learnt from the Kazakh Tennis Federation. …read more Source::...

      Trump refuses to testify at his impeachment trial
      Feb05

      Trump refuses to testify at his impeachment trial

      Trump’s Senate impeachment trial is due to begin next week. (AP pic)WASHINGTON: Former President Donald Trump’s lawyers on Thursday rejected a request from Democrats to testify at his impeachment trial in the US Senate next week, dismissing their invitation as a “public relations stunt”. Democrats in the House of Representatives...

      Top EU envoy jets to Moscow as outcry over Navalny grows
      Feb04

      Top EU envoy jets to Moscow as outcry over Navalny grows

      Protesters clash with police during a rally in Moscow on Sunday. (AP pic)MOSCOW: The outcry grew in Russia over the crackdown on peaceful protesters Thursday as EU foreign policy chief Josep Borrell was set to visit the country under pressure to confront Moscow over the imprisonment of opposition figure Alexei Navalny. Borrell’s visit – the...

      SOCAR opens new petrol station in Ukraine
      Feb04

      SOCAR opens new petrol station in Ukraine

      Azerbaijan’s State Oil Company’s subsidiary SOCAR Energy Ukraine has opened a new petrol station in Kyiv, Ukraine, bringing the number of such stations in this city to 13, Azertag has reported. …read more Source::...

      Three patients, doctor die in Ukraine COVID hospital fire
      Feb04

      Three patients, doctor die in Ukraine COVID hospital fire

      KYIV (Reuters) – Three intensive care patients and a ward doctor died overnight in a fire a hospital treating coronavirus cases in Zaporizhzhya, southeastern Ukraine, the region’s governor said on Thursday. Read full story …read more Source:: The...

      Covax issues distribution list for first vaccine wave
      Feb04

      Covax issues distribution list for first vaccine wave

      People line up to be administered Covid-19 vaccine at the Sion Municipal Hospital in Mumbai on Tuesday. (AP pic)GENEVA: The Covax programme to ensure equitable worldwide access to Covid-19 vaccines on Wednesday published its first distribution list, with enough doses for countries to immunise more than 3% of their populations by mid-2021. The...